FindTrial
Sign In

Effect of operation and expectant therapy for the prognosis of hemangiomas of liver in adults-a randomized control trial

Effect of operation and expectant therapy for the prognosis of hemangiomas of liver in adults-a randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000057
Enrollment
Unknown
Registered
2008-01-25
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemangiomas of liver in adults

Interventions

Group A:1. Patients who do not sign informed consent form
2. Patients with other occupying lesion in liver
Group B:Receiving operation to move the hemangioma or lobectomy of liver

Sponsors

The first hospital affiliated to Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults with hemangiomoas of liver (diameter>8cm) diagnosed by Type B ultrasound and enhancement Computer tomography.

Exclusion criteria

Exclusion criteria: 1. Patients who do not sign informed consent form; 2. Patients with other occupying lesion in liver.

Design outcomes

Primary

MeasureTime frame
Mortality;—

Secondary

MeasureTime frame
Symptom relief rate;Medical cost;—

Countries

China

Contacts

Public ContactMaimaitijiang.abudukadeer
mat760812@yahoo.com.cn+86 991 13999114475

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026